These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38411125)

  • 1. Anosmia or Ageusia Following COVID-19 Vaccination: A Systematic Review.
    Arabzadeh Bahri R; Esmaeilpur Abianeh F; Peisepar M; Hadi R; Basti FA; Maleki S; Radkhah H
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):164S-170S. PubMed ID: 38411125
    [No Abstract]   [Full Text] [Related]  

  • 2. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
    Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV
    Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination.
    Vaira LA; De Vito A; Lechien JR; Chiesa-Estomba CM; Mayo-Yàñez M; Calvo-Henrìquez C; Saussez S; Madeddu G; Babudieri S; Boscolo-Rizzo P; Hopkins C; De Riu G
    Laryngoscope; 2022 Feb; 132(2):419-421. PubMed ID: 34812498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.
    Lechien JR; Chiesa-Estomba CM; De Siati DR; Horoi M; Le Bon SD; Rodriguez A; Dequanter D; Blecic S; El Afia F; Distinguin L; Chekkoury-Idrissi Y; Hans S; Delgado IL; Calvo-Henriquez C; Lavigne P; Falanga C; Barillari MR; Cammaroto G; Khalife M; Leich P; Souchay C; Rossi C; Journe F; Hsieh J; Edjlali M; Carlier R; Ris L; Lovato A; De Filippis C; Coppee F; Fakhry N; Ayad T; Saussez S
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2251-2261. PubMed ID: 32253535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series.
    Cahuapaza-Gutierrez NL
    Lupus; 2024 Apr; 33(4):375-386. PubMed ID: 38315894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Smell and Taste in Patients With Suspected COVID-19: Analyses of Patients' Reports on Social Media.
    Koyama S; Ueha R; Kondo K
    J Med Internet Res; 2021 Apr; 23(4):e26459. PubMed ID: 33788699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
    Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
    J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
    Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
    Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine.
    Huhn G; Poorbaugh J; Zhang L; Beasley S; Nirula A; Brothers J; Welbel S; Wilson J; Gillani S; Weber KM; Morack R; Keckler K; Benschop RJ
    PLoS One; 2022; 17(9):e0273323. PubMed ID: 36083883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
    Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - A possible pattern? Observational study and review of the literature.
    Birlutiu V; Feiereisz AI; Oprinca G; Dobritoiu S; Rotaru M; Birlutiu RM; Iancu GM
    Int J Infect Dis; 2021 Jun; 107():72-77. PubMed ID: 33887455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients.
    Algahtani SN; Alzarroug AF; Alghamdi HK; Algahtani HK; Alsywina NB; Bin Abdulrahman KA
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status epilepticus as a complication of SARS-CoV-2 vaccination: Two case reports and systematic review with individual patients' data analysis.
    Dasara M; Dono F; Evangelista G; Quintieri P; Liviello D; Cipollone S; Tomassini V; Sensi SL
    Seizure; 2024 Oct; 121():8-16. PubMed ID: 39038383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of adults with noncritical COVID-19 two months after symptom onset.
    Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L
    Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Chemosensitive Neurological Disorders of Smell and Taste and Association with Blood Groups in SARS-CoV-2 Patients: Cross-Sectional Study.
    Al-Shouli ST; Meo SA; Alafaleq NO; Sumaily KM; Alshehri A; Almutairi A; Eidalsharif A; Alsulami F; Alhanaya S
    Viruses; 2023 May; 15(6):. PubMed ID: 37376577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
    Bird O; Galiza EP; Baxter DN; Boffito M; Browne D; Burns F; Chadwick DR; Clark R; Cosgrove CA; Galloway J; Goodman AL; Heer A; Higham A; Iyengar S; Jeanes C; Kalra PA; Kyriakidou C; Bradley JM; Munthali C; Minassian AM; McGill F; Moore P; Munsoor I; Nicholls H; Osanlou O; Packham J; Pretswell CH; San Francisco Ramos A; Saralaya D; Sheridan RP; Smith R; Soiza RL; Swift PA; Thomson EC; Turner J; Viljoen ME; Heath PT; Chis Ster I
    Epidemiol Infect; 2024 Jan; 152():e37. PubMed ID: 38250791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: A systematic review.
    Santos REA; da Silva MG; do Monte Silva MCB; Barbosa DAM; Gomes ALDV; Galindo LCM; da Silva Aragão R; Ferraz-Pereira KN
    Am J Otolaryngol; 2021; 42(2):102889. PubMed ID: 33445036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.